The page is the record's research on the issuer — no analyst, no rating, no view.

K Pharma,Inc. (4896) — research page

JP · jp-cm-kg/TSE-GROWTH/4896 · as of 2026-11-06

Identity and listing

The issuer is K Pharma,Inc., listed on the Growth Market under ticker 4896. Its ISIN is not on the record, and its LEI is not on the record. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.

fieldvaluesource · read date
nameK Pharma,Inc.source · 2026-11-06
exchangeGrowth Marketsource · 2026-11-06
ticker4896source · 2026-11-06
ISINnot on the record
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sector3250 Pharmaceuticalsource · 2026-11-06
jurisdictionJapan (EDINET domestic filer)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 8 filings in the twelve months to 2026-11-06, across 5 filing days. The median gap between filing days is 69.0 days. The latest filing is dated 2026-08-13, is of type regulatory_filing, and is 85 days before the record date. The Growth Market median cadence gap is 42 days across 598 issuers, with a median of 8.0 filings and a median latency of 85.0 days. The sector median cadence gap is 49.5 days across 80 issuers, with a median of 8.0 filings and a median latency of 85.0 days.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer86985
exchange median: Growth Market (598 issuers)84285
sector median: 3250 Pharmaceutical (80 issuers)849.585
datetypecategoryfiling
2026-08-13regulatory_filing135確認書
2026-08-13results半期報告書 (half-year report)半期報告書-第10期(2026/01/01-2026/12/31)
2026-03-30ad_hoc臨時報告書 (extraordinary report)臨時報告書
2026-03-24results有価証券報告書 (annual securities report)有価証券報告書-第9期(2025/01/01-2025/12/31)
2026-03-24regulatory_filing135確認書

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.

Orderability

For Qualified Institutional Investors the outcome is not determinable, and the signal is null. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Qualified Institutional Investorsnot determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope

rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations page. The count is 0.

Open research

The record holds 2 openly published research notes. The first is by FISCO Ltd., dated 2026-03-13. The second is by The Stock Research Center, dated 2023-11-01.

datepublishernotekind
2026-03-13FISCO Ltd.K Pharma Company Research and Analysis Reportissuer-sponsored
2023-11-01The Stock Research CenterK Pharma (4896 TSE Growth) Newly Listed Company Introduction Reportindependent

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. The issuer has no sealed years, the market's earliest sealed date is not on the record, and the live record began is not on the record.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
10.2
https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
10.3
https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4896 (the disclosure lines)
10.4
https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
10.5
https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XSVP (the auditor)
10.6
https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://www.fisco.co.jp/wordpress/wp-content/uploads/FISCO/kpharma20260313.pdf (open research)
10.8
https://holistic-r.org/adm/wp-content/uploads/2023/10/4896231020_en.pdf (open research)
10.9
https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4896 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"4896","exchange":"Growth Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:29a5e2603916a8bc.